SEER Cancer Statistics Review, 1975-2003

By L. Ries, D. Harkins, Martin F. Krapcho, A. Mariotto, B. Miller, E. Feuer, L. Clegg, M. Eisner, Marie-Josèphe Horner, N. Howlader and 3 more. 2006

9,332 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/1af159595d1a05cc271c92a64d139cb840c7f149

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Citations in the corpus

Breast Cancer Statistics (2013, background): “1); the median age at diagnosis of breast cancer was 61 years, with approximately 22 % new cases occurring under age 50, 36 % between ages 50 and 64, 29 % between ages 65 and 79, and 16 % at age 80 or above [15].”
The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. (2012, unknown): “For women with breast cancer in the United States between 2001-2007, 5-year relative survival varied from 99% for localised tumours to 84% for regional disease and 23% for distant stage disease [69].”
Cancer statistics, 2018 (2018, methodology): “For example, the 5-year relative survival rate for chronic myeloid leukemia increased from 22% for patients diagnosed in the mid-1970s to 68% for those diagnosed during 2007 through 2013.(8) Based on a review of clinical trial data, most patients with chronic myeloid leukemia who are treated with ty”
Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype (2007, background): “lower incidence of breast cancer compared with whites but a higher overall mortality.(2,8) In California the relative burden of invasive breast cancer varies by age and by race/ethnicity.”
From Detection of Individual Metastases to Classification of Lymph Node Status at the Patient Level: The CAMELYON17 Challenge (2019, background): “The prognosis of breast cancer patients is mainly determined by whether the cancer is organ-confined or has spread to other parts of the body [2].”
Annual Report to the Nation on the Status of Cancer, 1975–2006, Featuring Colorectal Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates (2010, methodology): “5% to 4% according to cancer site, race, and age group.(13,120) By using similar methods, cancer incidence rates for 2006 among men in the 31 NPCR registries that provided data to the CDC were underestimated between 0.”
Acute Myeloid Leukemia: Epidemiology and Etiology (2006, background): “leukemia.(4,7) Worldwide, the incidence of AML is highest in the U.”
Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. (2012, background): “These cancers typically have a poor prognosis, with 5-year survival rates in the range of 5% to 15%.(2,3) Surgical resection offers the only potentially curative option.”
Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival (2004, methodology): “However, the introduction of or improvements in early detection or diagnostic tests may increase observed survival rates spuriously by advancing the time of diagnosis of disease without prolonging life (lead-time bias), by the preferential detection of slower growing tumors (length-time bias), or by”
Future of cancer incidence in the United States: burdens upon an aging, changing nation. (2009, result): “The increase in minorities is also likely to impact cancer care, particularly as prior evidence suggests that certain minorities have higher cancer incidence rates and lower cancer survival rates as compared with white people.(5) In addition, minorities and older adults represent important populatio”
Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis (2014, methodology): “Survival rates provided by the Surveillance, Epidemiology, and End Results (SEER) program from 2003 to 2009 estimate 5-year survival rates among U.S. white males and females at 14.5% and 19.5%, respectively (Howlader et al. 2013).”